End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
24.42 CNY | +0.87% | -3.74% | +42.72% |
May. 13 | Lingrui Pharma Gets Green Light to Market Type 2 Diabetes Drug | MT |
Apr. 25 | Henan Lingrui Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+42.72% | 1.89B | |
+37.12% | 6.02B | |
-22.80% | 4.19B | |
+5.44% | 3.25B | |
-19.45% | 2.87B | |
-10.35% | 2.37B | |
-5.87% | 1.58B | |
-18.53% | 1.54B | |
-15.33% | 1.5B | |
+45.78% | 1.45B |
- Stock Market
- Equities
- 600285 Stock
- News Henan Lingrui Pharmaceutical Co., Ltd.
- Lingrui Pharma Gets Green Light to Market Type 2 Diabetes Drug